NSE
KOPRAN

Kopran Limited

Drug Manufacturers-General
Healthcare

Prices are adjusted according to historical splits.

Kopran Limited Stock Price

Vitals

Today's Low:
₹208.6
Today's High:
₹235.4
Open Price:
₹231.35
52W Low:
₹94.817
52W High:
₹249.8823
Prev. Close:
₹231.8
Volume:
156606

Company Statistics

Market Cap.:
₹11.81 billion
Book Value:
91.11
Revenue TTM:
₹5.42 billion
Operating Margin TTM:
6.33%
Gross Profit TTM:
₹1.89 billion
Profit Margin:
4.13%
Return on Assets TTM:
4.42%
Return on Equity TTM:
6.29%

Company Profile

Kopran Limited had its IPO on under the ticker symbol KOPRAN.

The company operates in the Healthcare sector and Drug Manufacturers-General industry. Kopran Limited has a staff strength of 902 employees.

Stock update

Shares of Kopran Limited opened at ₹231.35 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹208.6 - ₹235.4, and closed at ₹213.85.

This is a -7.74% slip from the previous day's closing price.

A total volume of 156,606 shares were traded at the close of the day’s session.

In the last one week, shares of Kopran Limited have slipped by -9.93%.

Kopran Limited's Key Ratios

Kopran Limited has a market cap of ₹11.81 billion, indicating a price to book ratio of 1.7801 and a price to sales ratio of 1.4257.

In the last 12-months Kopran Limited’s revenue was ₹5.42 billion with a gross profit of ₹1.89 billion and an EBITDA of ₹466.74 million. The EBITDA ratio measures Kopran Limited's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Kopran Limited’s operating margin was 6.33% while its return on assets stood at 4.42% with a return of equity of 6.29%.

In Q2, Kopran Limited’s quarterly earnings growth was a negative -63.3% while revenue growth was a negative 6.9%.

Kopran Limited’s PE and PEG Ratio

Forward PE
0
Trailing PE
52.6774
PEG

Its diluted EPS in the last 12-months stands at ₹4.65 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Kopran Limited’s profitability.

Kopran Limited stock is trading at a EV to sales ratio of 1.6123 and a EV to EBITDA ratio of 10.076. Its price to sales ratio in the trailing 12-months stood at 1.4257.

Kopran Limited stock pays annual dividends of ₹0 per share, indicating a yield of 1.35% and a payout ratio of 64.52%.

Balance sheet and cash flow metrics

Total Assets
₹6.50 billion
Total Liabilities
₹1.77 billion
Operating Cash Flow
₹0
Capital Expenditure
₹0
Dividend Payout Ratio
64.52%

Kopran Limited ended 2024 with ₹6.50 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹6.50 billion while shareholder equity stood at ₹4.39 billion.

Kopran Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹1.77 billion in other current liabilities, 482106000.00 in common stock, ₹3.91 billion in retained earnings and ₹58000.00 in goodwill. Its cash balance stood at ₹73.97 million and cash and short-term investments were ₹126.51 million. The company’s total short-term debt was ₹573,461,000 while long-term debt stood at ₹178.92 million.

Kopran Limited’s total current assets stands at ₹3.99 billion while long-term investments were ₹0 and short-term investments were ₹711000.00. Its net receivables were ₹1.63 billion compared to accounts payable of ₹873.81 million and inventory worth ₹1.31 billion.

In 2024, Kopran Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, Kopran Limited paid ₹0.65 in dividends in 2024.

Other key metrics

Current Trading Price
₹213.85
52-Week High
₹249.8823
52-Week Low
₹94.817
Analyst Target Price

Kopran Limited stock is currently trading at ₹213.85 per share. It touched a 52-week high of ₹249.8823 and a 52-week low of ₹249.8823. Analysts tracking the stock have a 12-month average target price of .

Its 50-day moving average was ₹192.23 and 200-day moving average was ₹154.82 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 4932.8% of the company’s stock are held by insiders while 0.3% are held by institutions.

Frequently Asked Questions About Kopran Limited

The stock symbol (also called stock or share ticker) of Kopran Limited is KOPRAN

The IPO of Kopran Limited took place on

Similar Industry Stocks (Drug Manufacturers-General)

Last Price
Chg
Chg%
₹4.95
-0.25
-4.81%
₹0
0
0%
MPHASIS LTD. (MPHASIS)
₹2467.9
-4.35
-0.18%
NTPC Limited (532555)
₹234.9
-8.05
-3.31%
₹49.72
0.17
+0.34%
₹1.3
-0.18
-12.16%
₹49.22
-3.84
-7.24%
₹1.79
-0.08
-4.28%
₹0.65
-0.01
-1.1%
₹72.03
-6.52
-8.3%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
₹0.14
0.07
+100%
₹0.12
0.04
+45.29%
₹0.96
0.05
+5.4%
₹1.34
-0.35
-20.71%
Humbl Inc (HMBL)
₹0
0
0%

Top Gainers

Last Price
Chg
Chg%
₹0
0
+172200%
₹0
0
+51200%
₹283
280.03
+9428.62%
₹11.2
10.57
+1667.68%
Latch Inc (LTCHW)
₹0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
₹0.19
-123.15
-99.85%
₹0
-0.11
-99.55%
₹0
-0
-97.96%
₹0
-0.01
-93.94%
₹0.01
-0.06
-92.24%

About

Kopran Limited, an integrated pharmaceutical company, manufactures and sells active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, syrups, dry powder, suspension, and injectables, as well as topical preparations. It also provides drugs in the categories of macrolide, antibacterial, anticonvulsant, anti-hypertensive, anti-helmentics, anti-histamine, anti-acne, anti-infective, urological, anti-thrombotic, antidiabetic, pain management, gastroenterology, and cardiovascular. In addition, the company provides drugs for erectile dysfunction, antiallergics, respiratory, oncology, central nervous system, antiprotozoal, anthelmintics, antipeptic ulcer and gut, and others. Kopran Limited was incorporated in 1958 and is headquartered in Mumbai, India.

Address

Parijat House, Mumbai, India, 400018